Great Teams Don’t Just Happen
How to support employee mental health and create a happy and productive team. PHARMExcel explores new well-being initiatives for office and remote workers.
PHARMExcel are pleased to announce their latest Lancet publication on Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters
How working with an agile CRO gets you more from your clinical trial budget
The process of taking a pharmaceutical drug through its drug discovery pathway can be challenging, time consuming, and expensive. It’s why more and more leading biotech and pharma companies choose to outsource clinical research work to contract research organisations (CROs) instead.
PHARMExcel are pleased to announce the publication of the persistence of immunogenicity after seven Covid -19 vaccines given as third boosters
PHARMExcel celebrates 13 successful years!
This month PHARMExcel reaches yet another milestone as it celebrates 13 years of successful business.
PHARMExcel are delighted to announce their future collaboration with DIOSynVax to support the delivery of their forthcoming clinical trial program.
This programme, (supported by CEPI funding), will provide the infrastructure to help design and select the lead antigen through proof-of-concept preclinical studies, progressing to initial clinical development through Phase I/II studies. DIOSynVax aim to establish clinical proof of concept for a novel vaccine candidate with the potential to provide broad protection against Sarbecovirus, Merbecovirus, Embecovirus and Nobecovirus.
Adopting a New Agile Approach to CRO Clinical Trial Management
Following its reputation of excellence in delivering investigator-led studies, PHARMExcel was selected to manage the Covid-19 vaccine booster study.
Employee Spotlight: Krishna Askoolam
Meet Krishna Askoolam, Clinical Trials Administrator: “This is my first role fresh out of University having graduated with a First-Class Honours degree in Biochemistry from the University of Kent…”
New EU Clinical Trial Regulation
The new EU clinical trial regulation (CTR) is set to revolutionise clinical trial processes across Europe impacting all European Member states and organisations wanting to run clinical trials across these regions. How can organisations prepare for the change and set themselves up successfully with a new CTR programme?